Medical Communications

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

The October edition of Pharmafocus is now live! You can read it here.

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …

Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …